Status: Recruiting
Carboplatin/Paclitaxel + Pembrolizumab for Locoregionally Advanced Penile Cancer
This is a single-armed, single-centre, non-blinded phase II trial to assess efficacy of induction chemo-immunotherapy for resectable node-positive squamous cell carcinoma of the penis
Participants needed: 27
Trial details
Phase: Phase 2Age: 18+Biological sex: MaleType: InterventionalSponsor: The Netherlands Cancer InstituteUpdated: Dec 8, 2025Locations: 2
Eligibility criteria
The participant (or legally acceptable representative if applicable) provides wr... [+8]
Has received prior therapy with an anti-PD-1, anti-PD-L1, or anti-PD-L2 agent or... [+18]